BSE Live
Oct 03, 16:01Prev. Close
1394.55
Open Price
1380.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Cash Flow of 3B BlackBio Dx (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 63.93 | 46.44 | 2.65 | 8.46 | 2.08 | |
Net CashFlow From Operating Activities | 44.47 | 28.47 | 1.65 | 7.98 | 2.79 | |
Net Cash Used In Investing Activities | -33.64 | -20.32 | -0.02 | -1.52 | -0.17 | |
Net Cash Used From Financing Activities | -3.07 | -3.62 | -2.57 | -6.31 | -1.59 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | 7.76 | 4.53 | -0.95 | 0.14 | 1.02 | |
Cash And Cash Equivalents Begin of Year | 54.88 | 50.35 | 1.85 | 1.71 | 0.69 | |
Cash And Cash Equivalents End Of Year | 62.63 | 54.88 | 0.90 | 1.85 | 1.71 |
05.06.2025
3B BlackBio Dx Standalone March 2025 Net Sales at Rs 23.02 crore, up 4.7% Y-o-Y
03.06.2025
3B BlackBio Dx Consolidated March 2025 Net Sales at Rs 22.50 crore, down 2.19% Y-o-Y
05.03.2025
3B BlackBio Dx Consolidated December 2024 Net Sales at Rs 25.39 crore, up 43.71% Y-o-Y
28.11.2024
3B BlackBio Dx Consolidated September 2024 Net Sales at Rs 29.15 crore, up 52% Y-o-Y
05.06.2025
3B BlackBio Dx Standalone March 2025 Net Sales at Rs 23.02 crore, up 4.7% Y-o-Y
03.06.2025
3B BlackBio Dx Consolidated March 2025 Net Sales at Rs 22.50 crore, down 2.19% Y-o-Y
05.03.2025
3B BlackBio Dx Consolidated December 2024 Net Sales at Rs 25.39 crore, up 43.71% Y-o-Y
28.11.2024
3B BlackBio Dx Consolidated September 2024 Net Sales at Rs 29.15 crore, up 52% Y-o-Y